VIP Research Hub — Vasoactive Intestinal Peptide Studies
VIP (vasoactive intestinal peptide) is a 28-residue neuropeptide widely cited in neuro-regulatory, vasodilatory and immune-modulation research literature, signalling primarily through the VPAC1 and VPAC2 receptors.
What this hub covers
- VPAC1 / VPAC2 G-protein-coupled receptor signalling
- Neuro-regulatory and vasodilatory research literature
- Immunomodulatory research models
- Reconstitution and storage
VIP research articles
All research →VIP (Vasoactive Intestinal Peptide) Research Overview
Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuropeptide and potent anti-inflammatory immunomodulator expressed throughout the nervous system, gut, lung, and immune cells — studied for autoimmune disease attenuation, pulmonary arterial hypertension, circadian rhythm regulation, neuroprotection, and acute inflammatory lung injury across decades of preclinical and clinical research.
Read article →Related research hubs
Researchers studying VIP commonly cross-reference these compounds.
VIP research FAQ
- What is VIP?
- VIP is a 28-amino-acid neuropeptide belonging to the secretin/glucagon superfamily, widely cited in neuro-regulatory, vasodilatory and immune-modulation research.
All content on this hub is provided strictly for laboratory research purposes. Compounds listed are not for human or veterinary consumption. See our research-use disclosure for full terms.